Cargando…

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B

BACKGROUND & AIMS: Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this study was to assess PRO scores in untreated p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buti, Maria, Stepanova, Maria, Palom, Adriana, Riveiro-Barciela, Mar, Nader, Fatema, Roade, Luisa, Esteban, Rafael, Younossi, Zobair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141931/ https://www.ncbi.nlm.nih.gov/pubmed/34041466 http://dx.doi.org/10.1016/j.jhepr.2021.100280

Ejemplares similares

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
por: Roade, Luisa, et al.
Publicado: (2023)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
por: Riveiro-Barciela, Mar, et al.
Publicado: (2020)

Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
por: Cortese, Maria Francesca, et al.
Publicado: (2022)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
por: Palom, Adriana, et al.
Publicado: (2022)

Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity
por: Younossi, Zobair M., et al.
Publicado: (2017)

ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype
por: Roade, Luisa, et al.
Publicado: (2022)

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)
por: Birerdinc, Aybike, et al.
Publicado: (2012)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
por: Riveiro-Barciela, Mar, et al.
Publicado: (2021)

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
por: Younossi, Zobair, et al.
Publicado: (2017)

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain
por: Palom, Adriana, et al.
Publicado: (2023)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
por: Younossi, Zobair M, et al.
Publicado: (2012)

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
por: Homs, Maria, et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection
por: Riveiro-Barciela, Mar, et al.
Publicado: (2014)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19
por: Vargas‐Accarino, Elena, et al.
Publicado: (2022)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
por: Caballero, Andrea, et al.
Publicado: (2015)

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
por: Pacin-Ruiz, Beatriz, et al.
Publicado: (2022)

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
por: Casillas, Rosario, et al.
Publicado: (2018)

Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection
por: Godoy, Cristina, et al.
Publicado: (2019)

Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study
por: Younossi, Zobair M., et al.
Publicado: (2016)

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study
por: Younossi, Zobair M, et al.
Publicado: (2014)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
por: García-García, Selene, et al.
Publicado: (2022)

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor
por: Stepanova, Maria, et al.
Publicado: (2016)

Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example
por: Page, Sandra, et al.
Publicado: (2013)

Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
por: Cortese, Maria Francesca, et al.
Publicado: (2021)

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy
por: González, Carolina, et al.
Publicado: (2018)

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
por: Stepanova, Maria, et al.
Publicado: (2017)

Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC
por: Younossi, Zobair M., et al.
Publicado: (2023)

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
por: Younossi, Zobair M., et al.
Publicado: (2022)

Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States
por: Golabi, Pegah, et al.
Publicado: (2016)

Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease
por: Younossi, Zobair, et al.
Publicado: (2022)

Non-Invasive markers for hepatic fibrosis
por: Baranova, Ancha, et al.
Publicado: (2011)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management
por: Grau-López, Lara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fjauhvqed82sctuu3ftgatmou3